comparemela.com

Latest Breaking News On - Canonic ltd - Page 6 : comparemela.com

Evogene Schedules Third Quarter of 2022 Financial Results Release & Conference Call for November 17, 2022

/PRNewswire/ Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development.

Lavie Bio Advances Its Novel Bio-Fungicide Program And Applies To The U S EPA For Regulatory Approval

vimarsana © 2020. All Rights Reserved.